EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED DISEASES

Clinical trials for EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED DISEASES explained in plain language.

Never miss a new study

Get alerted when new EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED DISEASES trials appear

Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental cell therapy targets dangerous virus in vulnerable patients

Disease control Recruiting now

This study is testing whether an experimental cell therapy called tabelecleucel can help control diseases caused by the Epstein-Barr virus in people with weakened immune systems. The trial includes 190 participants who have developed serious conditions like lymphomas or sarcomas …

Matched conditions: EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED DISEASES

Phase: PHASE2 • Sponsor: Pierre Fabre Medicament • Aim: Disease control

Last updated Mar 12, 2026 13:52 UTC

EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED DISEASES

Get alerted when new EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED DISEASES trials appear

Experimental cell therapy targets dangerous virus in vulnerable patients